AS
VRTX icon

Altshuler Shaham’s Vertex Pharmaceuticals VRTX Stock Holding History

Altshuler Shaham’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.9K Buy
24
+15
+167% +$6.65K ﹤0.01% 316
2026
Q1 		$4.02K Buy
+9
New +$4.2K ﹤0.01% 323
2025
Q4 		– Sell
-3,020
Closed -$1.18M – 470
2025
Q3 		$1.18M Hold
3,020
– – 0.02% 76
2025
Q2 		$1.34M Hold
3,020
– – 0.04% 65
2025
Q1 		$1.46M Hold
3,020
– – 0.04% 51
2024
Q4 		$1.22M Buy
+3,020
New +$1.4M 0.04% 48
2024
Q3 		– Sell
-3,000
Closed -$1.41M – 362
2024
Q2 		$1.41M Sell
3,000
-655
-18% -$284K 0.05% 42
2024
Q1 		$1.53M Sell
3,655
-847
-19% -$358K 0.06% 34
2023
Q4 		$1.83M Buy
4,502
+4,435
+6,619% +$1.64M 0.1% 22
2023
Q3 		$23.3K Sell
67
-19
-22% -$6.64K ﹤0.01% 211
2023
Q2 		$30.3K Buy
+86
New +$29K ﹤0.01% 233
2023
Q1 		– Sell
-513
Closed -$148K – 464
2022
Q4 		$148K Sell
513
-184
-26% -$56.1K 0.01% 109
2022
Q3 		$204K Sell
697
-119
-15% -$34.2K 0.01% 124
2022
Q2 		$230K Sell
816
-225
-22% -$60.2K ﹤0.01% 125
2022
Q1 		$272K Buy
+1,041
New +$247K ﹤0.01% 193
2021
Q3 		– Sell
-140
Closed -$28K – 675
2021
Q2 		$28K Buy
+140
New +$29.3K ﹤0.01% 519
2020
Q4 		– Sell
-443
Closed -$121K – 473
2020
Q3 		$121K Sell
443
-1,248
-74% -$344K ﹤0.01% 163
2020
Q2 		$491K Sell
1,691
-505
-23% -$137K 0.01% 102
2020
Q1 		$523K Buy
2,196
+2,054
+1,446% +$471K 0.02% 84
2019
Q4 		$31K Buy
142
+82
+137% +$16.6K ﹤0.01% 219
2019
Q3 		$10K Buy
+60
New +$10.6K ﹤0.01% 282
2019
Q2 		– Sell
-44
Closed -$8K – 399
2019
Q1 		$8K Sell
44
-1
-2% -$185 ﹤0.01% 269
2018
Q4 		$7K Buy
+45
New +$7.8K ﹤0.01% 244

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Altshuler Shaham's VRTX Position: Q2 2026 in Review

Altshuler Shaham increased its Vertex Pharmaceuticals (VRTX) stake by 167% in Q2 2026, buying an estimated $6.65K and bringing the position to 24 shares worth $11.9K. The position accounts for ﹤0.01% of the portfolio, ranked #316.

Altshuler Shaham first reported a position in VRTX in Q4 2018 and has held it in 23 quarters since. The position peaked at $1.83M in Q4 2023. 1,761 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Altshuler Shaham held 24 shares of Vertex Pharmaceuticals worth $11.9K as of Q2 2026.
  • Altshuler Shaham bought 15 Vertex Pharmaceuticals shares in Q2 2026, an estimated $6.65K.
  • Vertex Pharmaceuticals made up ﹤0.01% of Altshuler Shaham's portfolio in Q2 2026, its #316 holding.
  • Altshuler Shaham first reported a position in Vertex Pharmaceuticals in Q4 2018 and has held it in 23 quarters since.
  • Altshuler Shaham's Vertex Pharmaceuticals position peaked at $1.83M in Q4 2023.
  • 1,761 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Altshuler Shaham's 13F filing for Q2 2026, filed 12 Aug 2026.